RWPA
Richard W. Paul & Associates’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $956K | Buy |
39,454
+7,100
| +22% | +$172K | 0.35% | 71 |
|
|
2025
Q1 | $820K | Buy |
32,354
+55
| +0.2% | +$1.39K | 0.32% | 78 |
|
|
2024
Q4 | $857K | Buy |
32,299
+607
| +2% | +$16.1K | 0.31% | 89 |
|
|
2024
Q3 | $917K | Buy |
31,692
+494
| +2% | +$14.3K | 0.33% | 88 |
|
|
2024
Q2 | $873K | Sell |
31,198
-5,159
| -14% | -$144K | 0.34% | 80 |
|
|
2024
Q1 | $1.01M | Buy |
36,357
+8,639
| +31% | +$240K | 0.4% | 66 |
|
|
2023
Q4 | $798K | Buy |
27,718
+221
| +0.8% | +$6.36K | 0.34% | 77 |
|
|
2023
Q3 | $912K | Buy |
27,497
+5,821
| +27% | +$193K | 0.42% | 66 |
|
|
2023
Q2 | $795K | Buy |
21,676
+1,312
| +6% | +$48.1K | 0.35% | 83 |
|
|
2023
Q1 | $831K | Sell |
20,364
-829
| -4% | -$33.8K | 0.38% | 75 |
|
|
2022
Q4 | $1.09M | Buy |
+21,193
| New | +$1.09M | 0.55% | 44 |
|